V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003879 | 210011965 | 1.72 | 73.2 | Palliative (P) | 2021-06-03 | 2021-06-18 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB | 100017528 |
| 210003028 | 210012232 | 1.66 | 78.3 | Adjuvant (A) | null | 2018-06-19 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101552841 |
| 210003031 | 210012233 | 1.58 | null | Adjuvant (A) | 2016-11-25 | 2017-06-13 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100220188 |
| 210003034 | 210012234 | 1.76 | 58.6 | Adjuvant (A) | null | 2020-01-15 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101051849 |
| 210003042 | 210012236 | 1.64 | 69 | Adjuvant (A) | 2020-04-24 | 2020-08-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100806680 |
| 210003043 | 210012237 | 1.72 | 64 | Adjuvant (A) | 2018-06-30 | 2019-06-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100052869 |
| 210003053 | 210012239 | 1.55 | 123.8 | Adjuvant (A) | 2022-05-14 | 2022-05-29 | Trastuzumab | 02 | N | TRASTUZUMAB | 100836399 |
| 210003055 | 210012240 | 1.65 | 82 | Adjuvant (A) | 2017-05-09 | 2017-07-25 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101391093 |
| 210003060 | 210012241 | 1.64 | 92 | Adjuvant (A) | null | 2016-06-22 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100109764 |
| 210003064 | 210012242 | null | 72.1 | null | 2018-07-23 | 2018-08-24 | Docetaxel | null | null | DOCETAXEL | 101238725 |
| 210003066 | 210012243 | 1.52 | 81.2 | Adjuvant (A) | 2020-01-25 | 2020-05-12 | Trastuzumab 21 day loading dose | null | N | TRASTUZUMAB | 100325285 |
| 210003067 | 210012244 | 1.54 | 46.4 | Adjuvant (A) | 2019-03-28 | 2019-08-05 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101080806 |
| 210003068 | 210012245 | 1.6 | 113.5 | null | null | 2019-03-18 | Docetaxel | 02 | N | DOCETAXEL | 100586804 |
| 210003070 | 210012246 | 1.52 | 62 | null | 2020-09-07 | 2020-11-23 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 100030471 |
| 210003071 | 210012247 | 1.71 | 88 | Adjuvant (A) | 2021-06-27 | 2021-08-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100420339 |
| 210003072 | 210012248 | 1.66 | 106.4 | null | 2019-10-15 | 2019-11-21 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100458010 |
| 210003074 | 210012249 | 1.44 | 50.4 | Adjuvant (A) | 2019-12-18 | 2020-01-23 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101289124 |
| 210003088 | 210012251 | 1.56 | 81 | Adjuvant (A) | 2016-03-15 | 2017-08-03 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100999924 |
| 210003090 | 210012252 | 1.56 | 56.2 | Adjuvant (A) | 2020-04-30 | 2020-07-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100973773 |
| 210003091 | 210012253 | 1.69 | 64 | Adjuvant (A) | null | 2020-10-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100129135 |
| 210003092 | 210012254 | 1.54 | 83.9 | Palliative (P) | 2019-07-19 | 2019-09-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101342059 |
| 210003096 | 210012255 | 1.55 | 0 | Adjuvant (A) | null | 2020-07-01 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101042671 |
| 210003098 | 210012256 | 1.61 | 49.2 | null | null | 2020-10-24 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100777456 |
| 210003108 | 210012258 | 1.56 | null | Adjuvant (A) | 2017-04-29 | 2017-05-28 | Docetaxel | 02 | N | DOCETAXEL | 101031930 |
| 210003111 | 210012259 | 1.63 | 56 | Adjuvant (A) | null | 2019-04-17 | PACLITAXEL | null | N | PACLITAXEL | 100304112 |
| 210003114 | 210012261 | 1.62 | null | Palliative (P) | 2020-07-23 | 2020-09-26 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101455719 |
| 210003116 | 210012262 | 1.61 | 70 | Neo-adjuvant (N) | null | 2021-07-01 | PACLITAXEL | 02 | N | PACLITAXEL | 100706292 |
| 210003118 | 210012263 | 1.62 | null | Neo-adjuvant (N) | null | 2018-07-04 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100910715 |
| 210003119 | 210012264 | 1.59 | 51.8 | Adjuvant (A) | null | 2020-03-11 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101666789 |
| 210003121 | 210012265 | null | 80.5 | Curative (C) | 2022-01-04 | 2022-02-02 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100552009 |
| 210003129 | 210012266 | 1.67 | 55.1 | Adjuvant (A) | 2019-11-19 | 2020-01-24 | TRASTUZUMAB | 01 | N | TRASTUZUMAB | 101151851 |
| 210003135 | 210012267 | 1.67 | 69 | Adjuvant (A) | 2017-08-13 | 2017-10-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101066007 |
| 210003137 | 210012269 | 1.73 | 80 | Adjuvant (A) | 2017-04-19 | 2017-05-24 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101688526 |
| 210003146 | 210012271 | 1.67 | 58.2 | Neo-adjuvant (N) | null | 2022-04-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100641036 |
| 210003147 | 210012272 | 1.53 | 88.1 | null | 2019-01-16 | 2019-01-27 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101213383 |
| 210003148 | 210012273 | 1.66 | 66.25 | Palliative (P) | null | 2020-07-02 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100550953 |
| 210003150 | 210012275 | 1.63 | 63.6 | Curative (C) | 2021-01-10 | 2021-02-21 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101854643 |
| 210003151 | 210012276 | 1.48 | 65.6 | Adjuvant (A) | 2018-06-18 | 2018-09-04 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100910185 |
| 210003153 | 210012278 | 1.77 | 67 | Neo-adjuvant (N) | null | 2020-04-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101127410 |
| 210003158 | 210012279 | 1.57 | 65 | Neo-adjuvant (N) | 2021-07-27 | 2021-09-30 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100735496 |
| 210003162 | 210012281 | 1.5 | 59.1 | Adjuvant (A) | 2016-08-24 | 2016-10-26 | Docetaxel | null | null | DOCETAXEL | 100331511 |
| 210003164 | 210012282 | 1.55 | 75 | null | null | 2018-02-08 | Docetaxel | null | null | DOCETAXEL | 100322804 |
| 210003166 | 210012283 | null | 62.3 | null | 2021-03-05 | 2021-05-22 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100079108 |
| 210003167 | 210012284 | 1.7 | 72.6 | Adjuvant (A) | 2019-07-26 | 2019-11-14 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100092492 |
| 210003168 | 210012285 | 1.68 | 59.5 | Adjuvant (A) | 2020-05-01 | 2020-05-28 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101593551 |
| 210003177 | 210012287 | 1.54 | 62 | Adjuvant (A) | null | 2019-06-14 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100715959 |
| 210003189 | 210012290 | 1.58 | 106.9 | Adjuvant (A) | 2018-12-19 | 2019-03-07 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100328559 |
| 210003190 | 210012291 | 1.66 | 79.7 | Neo-adjuvant (N) | null | 2021-06-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100503820 |
| 210003193 | 210012292 | 1.51 | null | Palliative (P) | 2015-12-23 | 2019-01-26 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101684009 |
| 210003194 | 210012293 | 1.63 | 93.8 | Neo-adjuvant (N) | 2019-04-26 | 2019-07-09 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101493971 |